Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03253705 · ClinicalTrials.gov registry record

Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research

A clinical trial of Healthy Volunteers and Endothelial Dysfunction, sponsored by National Institutes of Health Clinical Center (CC).

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT03253705 is a study of Healthy Volunteers and Endothelial Dysfunction that is actively recruiting participants, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,000 participants, above the 478-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (109% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03253705, a study of Healthy Volunteers and Endothelial Dysfunction, is actively recruiting participants, sponsored by National Institutes of Health Clinical Center (CC).

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

Background: This study is designed to provide samples to help us study the genes your blood cells are making as well as the proteins, sugars, fats, vitamins and other metabolites found in your blood or urine. Blood samples may also be collected to make special cells. These are called induced pluripotent stem cells or iPSCs. Pluripotent stem cells are cells that can be converted into any type of cell. Researchers want to study in the lab iPSCs that are derived from blood samples. Objective: To collect samples to help study genes, proteins, sugars, fats, vitamins, and other metabolites found in blood or urine. Eligibility: Healthy volunteers and patients ages 18 and older Design: First-time research study participants at NIH will have an initial visit for this study that should last no more than 1 hour. All other visits should last 20 30 minutes. Participants will undergo a limited history and physical exam. Participants may have routine blood and urine tests. If participants are giving a blood sample, they must have a hemoglobin level checked in the past 12 months to make sure it is safe for them to give a blood sample for research. Participants may have a venous blood collection. They may do this at several visits. They will lie on a recliner or couch or sit in a chair. A needle will be placed into a vein in the hand or arm, using sterile techniques. Blood will be withdrawn into multiple syringes or tubes. Participants may be asked to provide urine in an appropriate container...

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2017-09-14
Est. Completion 2027-08-01

What the Registry Record Tells You About NCT03253705

The ClinicalTrials.gov registry entry for NCT03253705 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 478-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (109% higher). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 0 interventions.

NCT03253705 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03253705 about?

NCT03253705 is a clinical study titled "Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research". Background: This study is designed to provide samples to help us study the genes your blood cells are making as well as the proteins, sugars, fats, vitamins and other metabolites found in your blood or urine. Blood samples may also be collected to make special cells. These are called induced plurip...

What is the current status of trial NCT03253705?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-09-14. Estimated completion is 2027-08-01.

What conditions does trial NCT03253705 study?

This clinical trial studies the following conditions: Healthy Volunteers, Endothelial Dysfunction, Inflammation in Cardiopulmonary and Vascular Disease States.

Who is sponsoring clinical trial NCT03253705?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03253705 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.